Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience

Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience

Background & Aim. Transarterial chemoembolization (TACE) or sorafenib is recommended for hepatocellular carcinoma BCLC stages B and C respectively. We studied the role of combination of TACE and sorafenib in BCLC stages B/C.Material and methods. We undertook an observational study on a cohor...

Full description

Bibliographic Details
Main Authors: Joy Varghese, Chandan Kumar Kedarisetty, Jayanthi Venkataraman, Vijaya Srinivasan, Thiruchunapalli Deepashree, Mangerira Chinnappa Uthappa, Kaliamurthy Ilankumaran, Sanjay Govil, Mettu Srinivas Reddy, Mohamed Rela
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Annals of Hepatology
Subjects:
Hepatoma
Palliation
Chronic liver disease
Fibrosis
Liver transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303886

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119303886

Similar Items